Specialty Pharmacy

A phase 2 study demonstrated promising response rates and overall survival in patients with acute myeloid leukemia who were treated with azacitidine plus nivolumab.

Abeparvovec (Zolgensma) is a one-time infusion that replaces the defective or missing SMN1 gene with a functional copy that can create the SMN protein and prevent the loss of motor neurons in patients with spinal muscular atrophy.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Some of the oldest and most important drugs have suddenly been subject to very short supplies.

Robert F. Sidonio Jr, MD, assistant professor of pediatrics at Emory University, Children's Healthcare of Atlanta, gives an overview of the challenges associated with hemophilia management.

The American Society of Health-System Pharmacists (ASHP) kicked off its annual Midyear Clinical Meeting and Exhibition this Saturday in Anaheim, California.

Technological advances have widened the potential solutions to improve adherence to high-cost specialty drugs.

Top news of the day from across the health care landscape.

It’s our job to spend as much time as it takes to help patients feel comfortable with the medications they are taking.

Top news of the week from Specialty Pharmacy Times.

A look at last week's top stories in the world of pharmacy.

The FDA advises health care providers to counsel patients receiving alemtuzumab on symptoms related to stroke and arterial dissection.

Epstein-Barr virus and Kaposi's sarcoma herpesvirus can activate and lead to the growth of cancerous cells.

Top news of the day from across the health care landscape.

Amifampridine (Firdapse) is a first-in-class therapy for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder.

New platform would allow health care providers in developing nations to perform easy HIV testing and monitoring.

The drug’s application was designated for fast track and priority review, as well as orphan product status.

Rituximab-abbs (Truxima, Celltrion) is the fifteenth biosimilar approved by the FDA and the sixth biosimilar approved in 2018 thus far.

CVS Health announced that it has finalized its acquisition of Aetna with the promise to transform the consumer health experience.

Ron Lanton III, Esq., executive director and senior counsel for Frier Levitt Government Affairs, provides insight into the future of Any Willing Provider laws for the pharmacy industry.

Both actions follow similar recalls of valsartan-containing products by other manufacturers.

Amazon’s entry into the pharmacy space could be the start of significant changes in the specialty space.

Top news of the day from across the health care landscape.

Fostemsavir (ViiV Healthcare) may be a potential new option for patients with HIV who have become resistant to other medications.

Top news of the day from across the health care landscape.

A new study indicates that there are age-associated gender differences seen in the disease burden of chronic obstructive pulmonary disorder (COPD), with younger women more severely affected.

New recommendations urge health care providers to offer pre-exposure prophylaxis (PrEP) to individuals at high risk of HIV.

The FDA has granted an accelerated approval to larotrectinib for the treatment of adult and pediatric patients with solid tumors that have an NTRK gene fusion.

Top news of the day from across the health care landscape.